1. Home
  2. PGEN vs BBCP Comparison

PGEN vs BBCP Comparison

Compare PGEN & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • BBCP
  • Stock Information
  • Founded
  • PGEN 1998
  • BBCP 1983
  • Country
  • PGEN United States
  • BBCP United States
  • Employees
  • PGEN N/A
  • BBCP N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • BBCP Engineering & Construction
  • Sector
  • PGEN Health Care
  • BBCP Consumer Discretionary
  • Exchange
  • PGEN Nasdaq
  • BBCP Nasdaq
  • Market Cap
  • PGEN 292.6M
  • BBCP 370.5M
  • IPO Year
  • PGEN N/A
  • BBCP 2017
  • Fundamental
  • Price
  • PGEN $0.78
  • BBCP $7.15
  • Analyst Decision
  • PGEN Buy
  • BBCP Buy
  • Analyst Count
  • PGEN 5
  • BBCP 4
  • Target Price
  • PGEN $7.00
  • BBCP $7.67
  • AVG Volume (30 Days)
  • PGEN 905.3K
  • BBCP 92.1K
  • Earning Date
  • PGEN 11-14-2024
  • BBCP 01-09-2025
  • Dividend Yield
  • PGEN N/A
  • BBCP N/A
  • EPS Growth
  • PGEN N/A
  • BBCP N/A
  • EPS
  • PGEN N/A
  • BBCP 0.26
  • Revenue
  • PGEN $3,963,000.00
  • BBCP $434,594,000.00
  • Revenue This Year
  • PGEN N/A
  • BBCP N/A
  • Revenue Next Year
  • PGEN $426.76
  • BBCP N/A
  • P/E Ratio
  • PGEN N/A
  • BBCP $27.54
  • Revenue Growth
  • PGEN N/A
  • BBCP N/A
  • 52 Week Low
  • PGEN $0.76
  • BBCP $5.05
  • 52 Week High
  • PGEN $1.93
  • BBCP $8.48
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 39.38
  • BBCP 73.87
  • Support Level
  • PGEN $0.76
  • BBCP $7.05
  • Resistance Level
  • PGEN $0.97
  • BBCP $7.37
  • Average True Range (ATR)
  • PGEN 0.07
  • BBCP 0.27
  • MACD
  • PGEN -0.01
  • BBCP 0.11
  • Stochastic Oscillator
  • PGEN 7.90
  • BBCP 88.42

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.

Share on Social Networks: